哈药股份：注射用头孢哌酮钠舒巴坦钠通过仿制药一致性评价

Core Viewpoint - Harbin Pharmaceutical Group has received approval from the National Medical Products Administration for two formulations of injectable cefoperazone sodium and sulbactam sodium, indicating a successful evaluation of the consistency of quality and efficacy for these generic drugs [1] Group 1 - The company has obtained a supplement approval notice for injectable cefoperazone sodium sulbactam sodium (1:1) and (2:1) [1] - A total of four specifications for these drugs have passed the consistency evaluation [1]